Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity

标题
Lower serum fibroblast activation protein shows promise in the exclusion of clinically significant liver fibrosis due to non-alcoholic fatty liver disease in diabetes and obesity
作者
关键词
NAFLD fibrosis score, Fibroblast activation protein, Biomarker
出版物
DIABETES RESEARCH AND CLINICAL PRACTICE
Volume 108, Issue 3, Pages 466-472
出版商
Elsevier BV
发表日期
2015-03-12
DOI
10.1016/j.diabres.2015.02.024

向作者/读者发起求助以获取更多资源

Reprint

联系作者

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More